Browse
Submit Data
Databases
API
Help

Dataset Information

20 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Identification of COVID-19 Clinical Phenotypes by Principal Component Analysis-Based Cluster Analysis.

ABSTRACT: Background: COVID-19 has been quickly spreading, making it a serious public health threat. It is important to identify phenotypes to predict the severity of disease and design an individualized treatment. Methods: We collected data from 213 COVID-19 patients in Wuhan Pulmonary Hospital from January 1 to March 30, 2020. Principal component analysis (PCA) and cluster analysis were used to classify patients. Results: We identified three distinct subgroups of COVID-19. Cluster 1 was the largest group (52.6%) and characterized by oldest age, lowest cellular immune function, and albumin levels. 38.5% of subjects were grouped into Cluster 2. Most of the lab results in Cluster 2 fell between those of Clusters 1 and 3. Cluster 3 was the smallest cluster (8.9%), characterized by youngest age and highest cellular immune function. The incidence of respiratory failure, acute respiratory distress syndrome (ARDS), heart failure, and usage of non-invasive mechanical ventilation in Cluster 1 was significantly higher than others (P < 0.05). Cluster 1 had the highest death rate of 30.4% (P = 0.005). Although there were significant differences in age between Clusters 2 and 3 (P < 0.001), we found that there was no difference in demand for medical resources. Conclusions: We identified three distinct clusters of the COVID-19 patients. The results show that age alone could not be used to assess a patient's condition. Specifically, management of albumin, and immune function are important in reducing the severity of disease.

SUBMITTER: Ye W

PROVIDER: S-EPMC7690648 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

Identification of 6 dermatomyositis subgroups using principal component analysis-based cluster analysis.

Project description:ObjectiveDermatomyositis (DM) is a heterogeneous disease with a wide range of clinical manifestations. The aim of the present study was to identify the clinical subtypes of DM by applying cluster analysis.MethodsWe retrospectively reviewed the medical records of 720 DM patients and selected 21 variables for analysis, including clinical characteristics, laboratory findings, and comorbidities. Principal component analysis (PCA) was first conducted to transform the 21 variables into independent principal components. Patient classification was then performed using cluster analysis based on the PCA-transformed data. The relationships among the clinical variables were also assessed.ResultsWe transformed the 21 clinical variables into nine independent principal components by PCA and identified six distinct subgroups. Cluster A was composed of two sub-clusters of patients with classical DM and classical DM with minimal organ involvement. Cluster B patients were older and had malignancies. Cluster C was characterized by interstitial lung disease (ILD), skin ulcers, and minimal muscle involvement. Cluster D included patients with prominent lung, muscle, and skin involvement. Cluster E contained DM patients with other connective tissue diseases. Cluster F included all patients with myocarditis and prominent myositis and ILD. We found significant differences in treatment across the six clusters, with clusters E, C and D being more likely to receive aggressive immunosuppressive therapy.ConclusionWe applied cluster analysis to a large group of DM patients and identified 6 clinical subgroups, underscoring the need for better phenotypic characterization to help develop individualized treatments and improve prognosis.

| S-EPMC6771972 | biostudies-literature

Principal Component Analysis Applications in COVID-19 Genome Sequence Studies.

Project description:RNA genomes from coronavirus have a length as long as 32 kilobases, and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that caused the outbreak of coronavirus disease 2019 (COVID-19) pandemic has long sequences which made the analysis difficult. Over 20,000 sequences have been submitted to GISAID, and the number is growing fast each day which increased the difficulties in data analysis; however, genome sequence analysis is critical in understanding the COVID-19 and preventing the spread of the disease. In this study, a principal component analysis (PCA) was applied to the aligned large size genome sequences and the numerical numbers were converted from the letters using a published method designed for protein sequence cluster analysis. The study initialized with a shortlist sequence testing, and the PCA score plot showed high tolerance with low-quality data, and the major virus sequences from humans were separated from the pangolin and bat samples. Our study also successfully built a model for a large number of sequences with more than 20,000 sequences which indicate the potential mutation directions for the COVID-19 which can be served as a pretreatment method for detailed studies such as decision tree-based methods. In summary, our study provided a fast tool to analyze the high-volume genome sequences such as the COVID-19 and successfully applied to more than 20,000 sequences which may provide mutation direction information for COVID-19 studies.

| S-EPMC7804214 | biostudies-literature

Application of principal component analysis on temporal evolution of COVID-19.

Project description:The COVID-19 is one of the worst pandemics in modern history. We applied principal component analysis (PCA) to the daily time series of the COVID-19 death cases and confirmed cases for the top 25 countries from April of 2020 to February of 2021. We calculated the eigenvalues and eigenvectors of the cross-correlation matrix of the changes in daily accumulated data over monthly time windows. The largest eigenvalue describes the overall evolution dynamics of the COVID-19 and indicates that evolution was faster in April of 2020 than in any other period. By using the first two PC coefficients, we can identify the group dynamics of the COVID-19 evolution. We observed groups under critical states in the loading plot and found that American and European countries are represented by strong clusters in the loading plot. The first PC plays an important role and the correlations (C1) between the normalized logarithmic changes in deaths or confirmed cases and the first PCs may be used as indicators of different phases of the COVID-19. By varying C1 over time, we identified different phases of the COVID-19 in the analyzed countries over the target time period.

| S-EPMC8638895 | biostudies-literature

Spatial mapping of COVID-19 for Indian states using Principal Component Analysis.

Project description: Not available

| S-EPMC7834364 | biostudies-literature

Identification of differential gene pathways with principal component analysis.

Project description:MotivationDevelopment of high-throughput technology makes it possible to measure expressions of thousands of genes simultaneously. Genes have the inherent pathway structure, where pathways are composed of multiple genes with coordinated biological functions. It is of great interest to identify differential gene pathways that are associated with the variations of phenotypes.ResultsWe propose the following approach for detecting differential gene pathways. First, we construct gene pathways using databases such as KEGG or GO. Second, for each pathway, we extract a small number of representative features, which are linear combinations of gene expressions and/or their transformations. Specifically, we propose using (i) principal components (PCs) of gene expression sets, (ii) PCs of expanded gene expression sets and (iii) expanded sets of PCs of gene expressions, as the representative features. Third, we identify differential gene pathways as those with representative features significantly associated with the variations of phenotypes, particularly disease clinical outcomes, in regression models. The false discovery rate approach is used to adjust for multiple comparisons. Analysis of three gene expression datasets suggests that (i) the proposed approach can effectively identify differential gene pathways; (ii) PCs that explain only a small amount of variations of gene expressions may bear significant associations between gene pathways and phenotypes; (iii) including second-order terms of gene expressions may lead to identification of new differential gene pathways; (iv) the proposed approach is relatively insensitive to additional noises; and (v) the proposed approach can identify gene pathways missed by alternative approaches.Supplementary informationSupplementary data are available at Bioinformatics online.

| S-EPMC2732304 | biostudies-literature

Sparse Principal Component based High-Dimensional Mediation Analysis.

Project description:Causal mediation analysis aims to quantify the intermediate effect of a mediator on the causal pathway from treatment to outcome. When dealing with multiple mediators, which are potentially causally dependent, the possible decomposition of pathway effects grows exponentially with the number of mediators. An existing approach incorporated the principal component analysis (PCA) to address this challenge based on the fact that the transformed mediators are conditionally independent given the orthogonality of the principal components (PCs). However, the transformed mediator PCs, which are linear combinations of original mediators, can be difficult to interpret. A sparse high-dimensional mediation analysis approach is proposed which adopts the sparse PCA method to the mediation setting. The proposed approach is applied to a task-based functional magnetic resonance imaging study, illustrating its ability to detect biologically meaningful results related to an identified mediator.

| S-EPMC7449232 | biostudies-literature

PRINCIPAL COMPONENT ANALYSIS FOR EXPERIMENTS

Project description:Although principal component analysis is frequently used in multivariate/ analysis, it has disadvantages when applied to experimental or diagnostic data. First, the identified principal components have poor generality; since the size and directions of the components are dependent on the particular data set, the components are valid only within the set. Second, the method is sensitive to experimental noise and bias between sample groups, since it cannot reflect the design of experiments; rather, it estimates the same weight and independence of all the samples in the matrix. Third, the resulting components are often difficult to interpret. To address these issues, several options were introduced to the methodology. The resulting components were scaled to unify their size unit. Also, the principal axes were identified using training data sets and shared among experiments. This training data reflects the design of experiments, and its preparation allows noise to be reduced and group bias to be removed. The effects of these options were observed in microarray experiments, and showed an improvement in the separation of groups and robustness to noise. Additionally, unknown samples were appropriately classified using pre-arranged axes, and principal axes well reflected the characteristics of groups in the experiments. This SuperSeries is composed of the SubSeries listed below.

2011-08-15 | GSE31375 | GEO

Patch-Based Principal Component Analysis for Face Recognition.

Project description:We have proposed a patch-based principal component analysis (PCA) method to deal with face recognition. Many PCA-based methods for face recognition utilize the correlation between pixels, columns, or rows. But the local spatial information is not utilized or not fully utilized in these methods. We believe that patches are more meaningful basic units for face recognition than pixels, columns, or rows, since faces are discerned by patches containing eyes and noses. To calculate the correlation between patches, face images are divided into patches and then these patches are converted to column vectors which would be combined into a new "image matrix." By replacing the images with the new "image matrix" in the two-dimensional PCA framework, we directly calculate the correlation of the divided patches by computing the total scatter. By optimizing the total scatter of the projected samples, we obtain the projection matrix for feature extraction. Finally, we use the nearest neighbor classifier. Extensive experiments on the ORL and FERET face database are reported to illustrate the performance of the patch-based PCA. Our method promotes the accuracy compared to one-dimensional PCA, two-dimensional PCA, and two-directional two-dimensional PCA.

| S-EPMC5525078 | biostudies-other

Robust principal component analysis-based four-dimensional computed tomography.

Project description:The purpose of this paper for four-dimensional (4D) computed tomography (CT) is threefold. (1) A new spatiotemporal model is presented from the matrix perspective with the row dimension in space and the column dimension in time, namely the robust PCA (principal component analysis)-based 4D CT model. That is, instead of viewing the 4D object as a temporal collection of three-dimensional (3D) images and looking for local coherence in time or space independently, we perceive it as a mixture of low-rank matrix and sparse matrix to explore the maximum temporal coherence of the spatial structure among phases. Here the low-rank matrix corresponds to the 'background' or reference state, which is stationary over time or similar in structure; the sparse matrix stands for the 'motion' or time-varying component, e.g., heart motion in cardiac imaging, which is often either approximately sparse itself or can be sparsified in the proper basis. Besides 4D CT, this robust PCA-based 4D CT model should be applicable in other imaging problems for motion reduction or/and change detection with the least amount of data, such as multi-energy CT, cardiac MRI, and hyperspectral imaging. (2) A dynamic strategy for data acquisition, i.e. a temporally spiral scheme, is proposed that can potentially maintain similar reconstruction accuracy with far fewer projections of the data. The key point of this dynamic scheme is to reduce the total number of measurements, and hence the radiation dose, by acquiring complementary data in different phases while reducing redundant measurements of the common background structure. (3) An accurate, efficient, yet simple-to-implement algorithm based on the split Bregman method is developed for solving the model problem with sparse representation in tight frames.

| S-EPMC3395474 | biostudies-literature

Cluster analysis and clinical asthma phenotypes.

Project description:Heterogeneity in asthma expression is multidimensional, including variability in clinical, physiologic, and pathologic parameters. Classification requires consideration of these disparate domains in a unified model.To explore the application of a multivariate mathematical technique, k-means cluster analysis, for identifying distinct phenotypic groups.We performed k-means cluster analysis in three independent asthma populations. Clusters of a population managed in primary care (n = 184) with predominantly mild to moderate disease, were compared with a refractory asthma population managed in secondary care (n = 187). We then compared differences in asthma outcomes (exacerbation frequency and change in corticosteroid dose at 12 mo) between clusters in a third population of 68 subjects with predominantly refractory asthma, clustered at entry into a randomized trial comparing a strategy of minimizing eosinophilic inflammation (inflammation-guided strategy) with standard care.Two clusters (early-onset atopic and obese, noneosinophilic) were common to both asthma populations. Two clusters characterized by marked discordance between symptom expression and eosinophilic airway inflammation (early-onset symptom predominant and late-onset inflammation predominant) were specific to refractory asthma. Inflammation-guided management was superior for both discordant subgroups leading to a reduction in exacerbation frequency in the inflammation-predominant cluster (3.53 [SD, 1.18] vs. 0.38 [SD, 0.13] exacerbation/patient/yr, P = 0.002) and a dose reduction of inhaled corticosteroid in the symptom-predominant cluster (mean difference, 1,829 mug beclomethasone equivalent/d [95% confidence interval, 307-3,349 mug]; P = 0.02).Cluster analysis offers a novel multidimensional approach for identifying asthma phenotypes that exhibit differences in clinical response to treatment algorithms.

| S-EPMC3992366 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data